ScholarIQanswers from OpenAlex

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer

PaperCitations, authors & open-access status

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer have?

ScholarIQcitation count

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer has 317 citations in the OpenAlex counts ScholarIQ stores.

When was Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer published?

ScholarIQyear

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer?

ScholarIQoa status

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer has closed oa status in the ScholarIQ index.

What is the DOI of Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer?

ScholarIQdoi

The DOI for Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer is on the source record.

What is the PMID of Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer?

ScholarIQpmid

The PMID for Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer is on the source record.

What is the OpenAlex record for Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer?

ScholarIQopenalex

The OpenAlex for Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial